Avrobio Stock Price To Earnings To Growth
AVRODelisted Stock | USD 1.40 0.04 2.78% |
AVROBIO fundamentals help investors to digest information that contributes to AVROBIO's financial success or failures. It also enables traders to predict the movement of AVROBIO Stock. The fundamental analysis module provides a way to measure AVROBIO's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AVROBIO stock.
AVROBIO |
AVROBIO Company Price To Earnings To Growth Analysis
AVROBIO's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, AVROBIO has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
AVROBIO Fundamentals
Return On Equity | 0.43 | |||
Return On Asset | -0.35 | |||
Current Valuation | (26.51 M) | |||
Shares Outstanding | 44.89 M | |||
Shares Owned By Insiders | 1.65 % | |||
Shares Owned By Institutions | 68.80 % | |||
Number Of Shares Shorted | 139.56 K | |||
Price To Earning | (4.11) X | |||
Price To Book | 0.60 X | |||
EBITDA | (71.05 M) | |||
Net Income | 12.16 M | |||
Cash And Equivalents | 132.41 M | |||
Cash Per Share | 3.03 X | |||
Total Debt | 878 K | |||
Debt To Equity | 0.13 % | |||
Current Ratio | 11.11 X | |||
Book Value Per Share | 1.98 X | |||
Cash Flow From Operations | (63.19 M) | |||
Short Ratio | 0.70 X | |||
Earnings Per Share | 0.69 X | |||
Target Price | 2.0 | |||
Number Of Employees | 13 | |||
Beta | 1.22 | |||
Market Capitalization | 63.75 M | |||
Total Asset | 101.09 M | |||
Retained Earnings | (477.27 M) | |||
Working Capital | 93.91 M | |||
Current Asset | 30.6 M | |||
Current Liabilities | 3.26 M | |||
Net Asset | 101.09 M |
About AVROBIO Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AVROBIO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AVROBIO using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AVROBIO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AVROBIO
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AVROBIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will appreciate offsetting losses from the drop in the long position's value.Moving against AVROBIO Stock
0.87 | HYMTF | Hyundai Motor | PairCorr |
0.84 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.81 | TLK | Telkom Indonesia Tbk | PairCorr |
0.77 | EC | Ecopetrol SA ADR | PairCorr |
0.75 | SHG | Shinhan Financial | PairCorr |
The ability to find closely correlated positions to AVROBIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AVROBIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AVROBIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AVROBIO to buy it.
The correlation of AVROBIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AVROBIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AVROBIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AVROBIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in AVROBIO Stock
If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data |